The Clorox Company (NYSE:CLX) Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH increased its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 35.9% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 133,261 shares of the company's stock after buying an additional 35,228 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.11% of Clorox worth $19,623,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Redwood Park Advisors LLC purchased a new stake in Clorox in the 4th quarter valued at $26,000. Wood Tarver Financial Group LLC acquired a new position in Clorox in the fourth quarter valued at $31,000. GKV Capital Management Co. Inc. purchased a new stake in shares of Clorox in the fourth quarter valued at about $32,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of Clorox during the fourth quarter worth about $33,000. Finally, GW&K Investment Management LLC boosted its stake in shares of Clorox by 239.1% during the first quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock worth $43,000 after buying an additional 208 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.

Insiders Place Their Bets

In other news, Director Pierre R. Breber bought 4,000 shares of the firm's stock in a transaction on Wednesday, May 7th. The shares were bought at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the transaction, the director owned 4,000 shares in the company, valued at $546,280. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.57% of the stock is owned by insiders.

Clorox Price Performance

Shares of NYSE CLX traded down $0.62 during midday trading on Friday, hitting $130.80. The company had a trading volume of 1,287,038 shares, compared to its average volume of 1,776,629. The firm has a market capitalization of $16.12 billion, a price-to-earnings ratio of 23.48, a price-to-earnings-growth ratio of 3.44 and a beta of 0.51. The Clorox Company has a twelve month low of $117.35 and a twelve month high of $171.37. The business has a 50-day simple moving average of $126.77 and a two-hundred day simple moving average of $140.15. The company has a quick ratio of 0.44, a current ratio of 0.74 and a debt-to-equity ratio of 13.07.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. Clorox had a net margin of 9.89% and a return on equity of 324.23%. Clorox's revenue was down 8.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.71 earnings per share. Equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Wall Street Analyst Weigh In

CLX has been the topic of several recent research reports. Morgan Stanley dropped their price target on Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Wells Fargo & Company dropped their target price on Clorox from $142.00 to $135.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 9th. JPMorgan Chase & Co. cut their price target on Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a research note on Friday. Evercore ISI set a $140.00 price target on Clorox and gave the stock an "underperform" rating in a report on Tuesday, May 6th. Finally, Citigroup reissued a "neutral" rating and issued a $135.00 price objective (down from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Clorox has a consensus rating of "Hold" and a consensus target price of $144.83.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.